期刊文献+

肾癌的诊断和治疗探讨(附138例报告)

下载PDF
导出
摘要 目的探讨肾癌的诊断和治疗方法。方法回顾性分析1998年至2006年该院肾癌患者的诊治过程及其预后情况。138例患者术前都经过B超、CT、KUB+IVP等检查明确为肾实质性占位,Ⅰ~Ⅲ期行根治性肾癌手术,并于术后继续予以INF—a 3 mIU/d×3-18个月静滴或肌注,Ⅳ期行生物治疗或放疗化疗。结果随访3~72个月,Ⅰ期至今全部存活;Ⅱ期平均生存5-3年;Ⅲ期平均生存2.1年;Ⅳ期已全部死亡,平均生存4个月。结论医学影像学是肾癌的主要诊断方法。肾癌最有效的治疗手段是外科手术。术后进行生物治疗或放化疗能有效增强抗肿瘤的能力,提高生存率。
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第4期627-628,共2页 China Journal of Modern Medicine
  • 相关文献

参考文献9

  • 1顾方六.肾肿瘤.吴阶平泌尿外科学,2004,43:912-917.
  • 2KIN KA, CHOI JW, PARK CM, et al. Unusual renal cell carcinomas a pictorial essay [J]. Abdominal Imaging, 2006, 31 (2): 154-163.
  • 3李泉林,关宏伟,张秋萍,薛军,王法鹏,高鹤立,韩辉,张仁科.肾癌多中心病灶发生机理的探讨[J].中华泌尿外科杂志,2003,24(4):232-234. 被引量:30
  • 4STADLER WM. Therapeutic options for variant renal cancer: a true orphan disease[J]. Clin Cancer Res, 2004, 10: 6393-6639.
  • 5LERNER SE, HAWKINS CA, BLUTE ML, et al. Disease outcome in patients with two stage renal cell carcinoma treated with nephron sparing or radical surgery [J]. J Urol, 1996, 155: 1868-1873.
  • 6GHAVAMIAN R, CHEVILLE JC, LOHSE CM, et al. Renal. cell carcinoma in the solitary kidney: An analysis of complications and outcome after nephron sparing surgery[J]. J Urol, 2002, 168: 454-459.
  • 7FLANIGAN RC, MICKISCH G, SYLVESTER R, et al. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis[J]. J Urol, 2004, 171(3): 1071-1076.
  • 8GIACOSA R, SANTI R, VAGLIO A, et a.L "Late" regressions of metastases from renal cancer after a period of disease progression continuing the same intermittent low dose immunotherapy regimen [J]. Acta Biomed Ateneo Parmense, 2004, 75 (2): 126-130.
  • 9FISHMAN M, ANTONIA S. Specific antitumour vaccine for renal cancer[J]. Lancet, 2004, 363(9409): 583-584.

二级参考文献8

  • 1Junker K, Schlichter A, Hindermann W, et al. Genetic characterization of multifocal tumor growth in renal cell carcinoma. Kidney Int, 1999,56 : 1291-1294.
  • 2Haitel A, Wiener HG, Blasehitz U, et al. Biologic behavior of p53 overexpression in multifocal renal cell carcinoma of clear cell type.Cancer, 1999,85 : 1593-1598.
  • 3Morel QL, Clar BF, Fenollosa EB, et al. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in renal cell carcinoma. Anticancer Res, 1998,18:677-682.
  • 4Paradis V, Ferlicot S, Ghannam E, et al. CD44 is an independent prognostic factor in conventional renal cell carcinoma. J Urol, 1999,16 :1984-1987.
  • 5Stumm G, Eberwein S, Rostock-Wolf S, et al. Concomitant overexpression of the EGFR and erb B2 genes in renal cell carcinoma(RCC) is correlated with dedifferentiation and metastasis. Int J Cancer, 1996,69:17-22.
  • 6Eschewege P,Saunsine C,Delepaul B,et al. Radical nephrectomy for renal cell carcinoma 30 mm or less :long-term followup results. J Urol,1996,155 : 1196-1199.
  • 7邹高德,葛根,孙锡林,庄文华,吴绮明,张文昌.肾细胞癌抗凋亡基因bcl-2的免疫组化研究[J].中华泌尿外科杂志,1997,18(6):329-331. 被引量:12
  • 8范小玲,张祥生,郝元瑞,李启忠,单磊,郝元瑞.CD_(44)和nm23在肾脏肿瘤中表达及其临床意义[J].中华泌尿外科杂志,1999,20(9):551-553. 被引量:2

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部